Inovio Pharmaceuticals
INO
INO
218 hedge funds and large institutions have $693M invested in Inovio Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 88 increasing their positions, 51 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less call options, than puts
Call options by funds: $38.4M | Put options by funds: $44M
13% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 45
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
218
Holding in Top 10
–
Calls
$38.4M
Puts
$44M
Top Buyers
| 1 | +$37.2M | |
| 2 | +$30.4M | |
| 3 | +$21.4M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.39M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$7.28M |
Top Sellers
| 1 | -$7.06M | |
| 2 | -$6.94M | |
| 3 | -$5.93M | |
| 4 |
JG
Jefferies Group
New York
|
-$4.43M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.21M |